CCP puts patient benefit over patient choice in acute merger
The Co-operation and Competition Panel has advised, for the first time, that a merger between two rival providers can go ahead, because the potential benefits outweighed the reduction in patient choice.
Continue reading this article – simply subscribe below
Subscribing takes two minutes and you’ll immediately have full access to hsj.co.uk, plus the HSJ magazine delivered every week.
HSJ Subscribers:
If you are a Health Service Journal subscriber please sign in with your email address and click submit:
Not yet a subscriber?
Sign up today for immediate access to hsj.co.uk and Health Service Journal magazine
Alternatively, try our 14-day free trial subscription
